Close Menu

NEW YORK – Becton Dickinson disclosed this week that it is offering a total of $1.5 billion in notes to repay some debt and to fund a partial redemption of other notes.

In a document filed with the US Securities and Exchange Commission on Monday, the Franklin Lakes, New Jersey-based firm said it is offering $750 million aggregate principal amount of 2.823 percent notes due in 2030 and $750 million aggregate principal amount of 3.794 percent notes due in 2050. The notes will be payable in cash semiannually in arrears on May 20 and Nov. 20 of each year starting this November.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.